Research on the clinical application of psychedelics is gaining momentum. However major knowledge gaps remain regarding the mechanisms of action underlying beneficial therapeutic effects of these s
Pharmacology and Acute Effects of Different Psychedelics
- 11/09/2021
- 09:30 - 10:00
- Track 2: Bernhard von Langenbeck Room
Abstract
Current clinical trials with psychedelics mostly use psilocybin. However, there are other classic psychedelics such as LSD, DMT and mescaline that may be useful. The presentation will give an overview on the substances currently used in clinical trials and then focus on the acute effect characteristics of different psychedelics.
Related Events
Psychiatric disorders represent a major challenge for global health. According to the World Health Organization (WHO), approximately 300 million people worldwide suffer from depression, and even mo
Lea Mertens, MSc.
This presentation will go over the preliminary evidence for the efficacy and safety of psilocybin, a serotonergic psychedelic acting as a partial 5-HT2A agonist, in the treatment of treatment-resis
Prof. Dr. med. Franz X. Vollenweider
Recent integrative psychological and neuroscientific approaches to depression highlight that the self is a core dimension of depression. The self in depression is characterized by an increased self
